Ergo-Series of the OMNI® Surgical System by Sight Sciences, Inc.
The Ergo-Series maximizes ergonomics and surgical ease-of-use while continuing to enable surgeons to perform minimally invasive, implant-free glaucoma procedures
MENLO PARK, Calif., Sept. 28, 2022 (GLOBE NEWSWIRE) — Sight Sciences, Inc. (Nasdaq: SGHT), today announced that 12 ophthalmic physicians will present their first-hand experience using the OMNI Surgical System as a standalone minimally invasive glaucoma surgery (MIGS) during this year’s annual AAO convention at McCormick Place in Chicago, IL. Meeting delegates are invited to attend the four sessions throughout the weekend at the Sight Sciences booth (#4843) to learn more about OMNI standalone treatment and engage directly with the panelists. Additionally, the soon to be released Ergo-Series of the OMNI Surgical System and the recently launched SION Surgical Instrument will be showcased at AAO 2022 and available for hands-on demos at the booth.